Cargando…

Pulmonary hypertension: diagnostic and therapeutic challenges

Pulmonary hypertension (PH) is a hemodynamic and pathophysiologic state that can be found in multiple conditions with associated symptoms of dyspnea, decreased exercise tolerance, and progression to right heart failure. The World Health Organization has classified PH into five groups. The first grou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazan, Isabel S, Fares, Wassim H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544628/ https://www.ncbi.nlm.nih.gov/pubmed/26316767 http://dx.doi.org/10.2147/TCRM.S74881

Ejemplares similares

Macitentan for the treatment of pulmonary arterial hypertension
por: Kholdani, Cyrus A, et al.
Publicado: (2014)

Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges
por: Campo, Ilaria, et al.
Publicado: (2012)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
por: Spagnolo, Paolo, et al.
Publicado: (2012)

A systematic review of transition studies of pulmonary arterial hypertension specific medications
por: Sofer, Avraham, et al.
Publicado: (2017)

Safety and feasibility of obtaining wedged pulmonary artery samples and differential distribution of biomarkers in pulmonary hypertension
por: Fares, Wassim H., et al.
Publicado: (2012)

Diagnostic and therapeutic algorithm for pulmonary arterial hypertension
por: Desai, Ankit A., et al.
Publicado: (2011)

COVID-19 Associated Invasive Pulmonary Aspergillosis: Diagnostic and Therapeutic Challenges
por: Mohamed, Aia, et al.
Publicado: (2020)

Idiopathic and immune‐related pulmonary fibrosis: diagnostic and therapeutic challenges
por: McLean‐Tooke, Andrew, et al.
Publicado: (2019)

Reduced RVSWI Is Associated With Increased Mortality in Connective Tissue Disease Associated Pulmonary Arterial Hypertension
por: Clapham, Katharine R., et al.
Publicado: (2020)

Is hyponatremia associated with mortality in pulmonary arterial hypertension?
por: Rudkovskaia, Anastasiia A., et al.
Publicado: (2018)

Diagnostic Approach to Pulmonary Hypertension in Premature Neonates
por: Kumar, Vasantha H. S.
Publicado: (2017)

Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease
por: Lteif, Christelle, et al.
Publicado: (2021)

Lupus-Associated Pulmonary Arterial Hypertension: Variable Course and Importance of Prompt Recognition
por: Mensah, Kofi A., et al.
Publicado: (2015)

Pulmonary Hypertension in Pregnancy: Challenges and Solutions
por: Afify, Hesham, et al.
Publicado: (2022)

The challenges in paediatric pulmonary arterial hypertension
por: Beghetti, Maurice, et al.
Publicado: (2014)

Pulmonary Regurgitation after Tetralogy of Fallot Repair: A Diagnostic and Therapeutic Challenge
por: Senthilnathan, Selvi, et al.
Publicado: (2013)

Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)
por: Argula, Rahul G, et al.
Publicado: (2019)

AMPK and the Challenge of Treating Hypoxic Pulmonary Hypertension
por: Flores, Karen, et al.
Publicado: (2022)

Challenges in pulmonary hypertension: managing the unexpected
por: Olsson, Karen M., et al.
Publicado: (2015)

Do single or sequential measurements of leptin and adiponectin in plasma have prognostic value in pulmonary arterial hypertension?
por: Tonelli, Adriano R., et al.
Publicado: (2017)

Diagnostic advances and opportunities in chronic thromboembolic pulmonary hypertension
por: D'Armini, Andrea M.
Publicado: (2015)

Precision medicine: The future of diagnostic approach to pulmonary hypertension?
por: Kedzierski, Piotr, et al.
Publicado: (2019)

Group 3 pulmonary hypertension: Challenges and opportunities
por: McGettrick, Michael, et al.
Publicado: (2020)

Hypertension in Pregnancy: A Diagnostic and Therapeutic Overview
por: Cífková, Renata
Publicado: (2023)

Acute cough: a diagnostic and therapeutic challenge
por: Dicpinigaitis, Peter V, et al.
Publicado: (2009)

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
por: Moro, Jacopo, et al.
Publicado: (2022)

Complexity of macrophage migration inhibitory factor (MIF) and other angiogenic biomarkers profiling in pulmonary arterial hypertension
por: Marshall, Jeffrey D., et al.
Publicado: (2017)

Pulmonary Arterial Hypertension in a Patient with a Portosystemic Shunt: Diagnostic Challenge
por: Stepffer, Carolina, et al.
Publicado: (2020)

Novel diagnostic and therapeutic approaches to pulmonary hypertension due to the unilateral absence of a pulmonary artery
por: Nagamatsu, Yuki, et al.
Publicado: (2021)

Riociguat: Something new in pulmonary hypertension therapeutics?
por: Shanmugam, Elangovan, et al.
Publicado: (2015)

Overview of current therapeutic approaches for pulmonary hypertension
por: Stamm, Jason A., et al.
Publicado: (2011)

Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?
por: Lambert, Mélanie, et al.
Publicado: (2018)

Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension
por: Satoh, Kimio, et al.
Publicado: (2018)

Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension
por: García-Lunar, Inés, et al.
Publicado: (2020)

Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension
por: Redel-Traub, Gabriel, et al.
Publicado: (2022)

Unilateral absent pulmonary artery in an adult - A diagnostic and therapeutic challenge
por: Seedat, Faheem, et al.
Publicado: (2017)

Diagnostic and Therapeutic Challenges
por: Xuan, Yi, et al.
Publicado: (2019)

Diagnostic and Therapeutic Challenges
por: Yang, Kaibo, et al.
Publicado: (2020)

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities
por: Grinnan, Daniel, et al.
Publicado: (2019)

Anxiety and depression in patients with pulmonary hypertension: impact and management challenges
por: Bussotti, Maurizio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7tqrhkm5f2gs7bp5p76e24gpde